{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:54:51Z","timestamp":1791125691057,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3807,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Institut National du Cancer: PNES Poumon","award":["0610-301616-122\/PL 2006"],"award-info":[{"award-number":["0610-301616-122\/PL 2006"]}]},{"name":"Ligue contre le cancer: comit\u00e9 du Val de Marne"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1093\/annonc\/mdn785","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:12:58Z","timestamp":1237421578000},"page":"1257-1263","source":"Crossref","is-referenced-by-count":16,"title":["The NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinoma"],"prefix":"10.1016","volume":"20","author":[{"given":"D.","family":"Planchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Taranchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tredaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Caliandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Validire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdn785_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdn785_bb0015","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1158\/0008-5472.CAN-05-0551","article-title":"TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers","volume":"65","author":"Le Calvez","year":"2005","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdn785_bb0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6602707","article-title":"Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma","volume":"93","author":"Sonobe","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdn785_bb0025","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/annonc\/mdn785_bb0030","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/1078-0432.CCR-05-1981","article-title":"Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features","volume":"12","author":"Tam","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdn785_bb0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ijc.20761","article-title":"Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers","volume":"114","author":"Divine","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdn785_bb0040","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI15475","article-title":"Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples","volume":"111","author":"Wang","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdn785_bb0045","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/cncr.11183","article-title":"Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers","volume":"97","author":"Wong","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn785_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008215213739","article-title":"Carboplatin versus cisplatin in solid tumors: an analysis of the literature","volume":"9","author":"Lokich","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn785_bb0055","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdn785_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdn785_bb0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1101\/gad.13.7.768","article-title":"Molecular mechanism of nucleotide excision repair","volume":"13","author":"de Laat","year":"1999","journal-title":"Genes Dev"},{"key":"10.1093\/annonc\/mdn785_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","article-title":"ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy","volume":"16","author":"Metzger","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn785_bb0075","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1200\/JCO.2001.19.23.4298","article-title":"ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy","volume":"19","author":"Shirota","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn785_bb0080","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdn785_bb0085","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1093\/emboj\/16.21.6559","article-title":"Mechanism of open complex and dual incision formation by human nucleotide excision repair factors","volume":"16","author":"Evans","year":"1997","journal-title":"EMBO J"},{"key":"10.1093\/annonc\/mdn785_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-1119(99)00489-8","article-title":"Damage recognition in nucleotide excision repair of DNA","volume":"241","author":"Batty","year":"2000","journal-title":"Gene"},{"key":"10.1093\/annonc\/mdn785_bb0095","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1128\/MCB.24.13.5776-5787.2004","article-title":"The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks","volume":"24","author":"Niedernhofer","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1093\/annonc\/mdn785_bb0100","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.127.3.978","article-title":"ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer","volume":"127","author":"Simon","year":"2005","journal-title":"Chest"},{"key":"10.1093\/annonc\/mdn785_bb0105","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa065411","article-title":"DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer","volume":"356","author":"Zheng","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdn785_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/bmb\/ldl012","article-title":"Tobacco control: present and future","volume":"77\u201378","author":"West","year":"2006","journal-title":"Br Med Bull"},{"key":"10.1093\/annonc\/mdn785_bb0115","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/annonc\/mdi408","article-title":"Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers","volume":"16","author":"Dutu","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn785_bb0120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ijc.21183","article-title":"International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising","volume":"117","author":"Devesa","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdn785_bb0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/nar\/29.4.872","article-title":"Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair","volume":"29","author":"Gaillard","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1093\/annonc\/mdn785_bb0130","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1158\/0008-5472.CAN-04-0348","article-title":"Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents","volume":"64","author":"Youn","year":"2004","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdn785_bb0135","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1158\/0008-5472.CAN-06-3821","article-title":"GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells","volume":"67","author":"Andrieux","year":"2007","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdn785_bb0140","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)","volume":"366","author":"Thatcher","year":"2005","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdn785_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdn785_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2008.02.021","article-title":"Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer","author":"Okuda","year":"2008","journal-title":"Lung Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419410077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419410077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/20\/7\/1257\/987849\/mdn785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:52:27Z","timestamp":1624441947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419410077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0923753419410077"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdn785","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}